SF3B1 and myelodysplastic syndrome: At the level of the effect of mutations on prognosis, the presence of SF3B1 mutations was associated with shorter survival compared to patients without SF3B1; however, the survival of SF3B1-mutant MDS with isolated del(5q) was similar to that observed in SF3B1-mutant MDS without del(5q) [6].